ArticleEMBO reports2026

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

Chu-Han Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.